Hydroxyurea ≥98% Ribonucleotide reductase inhibitor
Over dit artikel
Ribonucleotide reductase inhibitor. Various biological activities including anticancer and antiretroviral properties. Induces apoptosis in vitro.
Caution: All products are FOR RESEARCH USE ONLY. PRODUCTS ARE NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES. Customer is granted a limited use non-exclusive licence for its own internal research. Any control manufacturer supplies with a Product is limited to use only to validate the relevant Product. By using the Product, Customers agree not to attempt to reverse engineer or otherwise perform any compositional, structural, functional or other analyses directed to learning the methodology, formulae, sequences, processes, make-up or production of any of the Products or portions thereof.
- CAS-nummer:127-07-1
- Molecular Weight:76,055 g/mol
2 Opties Hieronder Beschikbaar
Product Details & Documents
Ribonucleotide reductase inhibitor. Various biological activities including anticancer and antiretroviral properties. Induces apoptosis in vitro.
Caution: All products are FOR RESEARCH USE ONLY. PRODUCTS ARE NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES. Customer is granted a limited use non-exclusive licence for its own internal research. Any control manufacturer supplies with a Product is limited to use only to validate the relevant Product. By using the Product, Customers agree not to attempt to reverse engineer or otherwise perform any compositional, structural, functional or other analyses directed to learning the methodology, formulae, sequences, processes, make-up or production of any of the Products or portions thereof.
- CAS-nummer:127-07-1
- Molecular Weight:76,055 g/mol
Specifications for Product Family
Specificatie testresultaten
- Constituents::98% Hydroxyurea
Les recommandations seront personnalisées en fonction de vos préférences d’achat uniquement si vous avez donné votre consentement en activant l’option " Améliorer mon expérience d’achat " sur la page "Mon compte".
Dans le cas contraire, vous recevrez des recommandations génériques.



